NewsOrganoClick AB (publ) publishes its interim report for Q1 2017

“After the first four months of the year I can conclude that we are on the right path. Q1, which historically has been one of our weakest periods, and has contributed with 18 % of the yearly revenue, has started well. Sales has increased from SEK 6.5 million to SEK 18.0 million which excluding our previous acquisition gave an organic sales growth of 52 %. The fixed operational costs for the group (excluding the acquired business) increased with only 2 % compared with Q1 2016. The gross margin increased to 37 % compared with 32 % the same period 2016 and March became the first month ever for the group with a positive EBITDA. The trend has continued in April with strong sales and increased gross margin. The goal of a positive EBITDA for the full year therefore feels realistic.”

Translation from CEO Mårten Hellbergs comments to the Interim Report:

Q1, 1 Jan – 31 March 2017
The Group compared with 2016

  • The net revenue amounted to SEK 18.0 (6.5) million
  • Revenue growth of 174.4 % (23.4 %)
  • Organic sales growth (excluding acquisition) of 52 %
  • EBIT of SEK -6.5 (-7.9) million
  • March 2017 became the first month ever when the Group had positive EBITDA

The complete version of the Interim Report (in Swedish) is available on the companys´ homepage:
http://www.organoclick.com/investor-relations/reports/

For more information, please contact;
Mårten Hellberg, CEO OrganoClick
Phone: +46 8 684 001 10
Email: marten.hellberg@organoclick.com